Shopping Cart
Remove All
Your shopping cart is currently empty
Desfesoterodine (5-HMT) is a new muscarinic receptor antagonist with Kb of 0.84 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $60 | - | In Stock | |
| 5 mg | $147 | - | In Stock | |
| 10 mg | $228 | - | In Stock | |
| 25 mg | $392 | - | In Stock | |
| 50 mg | $578 | - | In Stock | |
| 100 mg | $833 | - | In Stock | |
| 500 mg | $1,690 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $162 | - | In Stock |
| Description | Desfesoterodine (5-HMT) is a new muscarinic receptor antagonist with Kb of 0.84 nM. |
| Targets&IC50 | mAChR:0.84 nM(Kb) |
| In vitro | Desfesoterodine is a major pharmacologically active metabolite of tolterodine. Desfesoterodine produces a competitive and concentration-dependent inhibition of carbachol-induced contraction of guinea-pig isolated urinary bladder strips. Desfesoterodine antagotizes muscarinic receptors with a pA2 of 9.1. Desfesoterodine causes a concentration-dependent inhibition of (-)3 H-QNB binding in homogenates of guinea-pig urinary bladder, parotid gland, heart and cerebral cortex. [1] Desfesoterodine has a similar pharmacological profile with tolterodine. [2] Intravenous infusion of Desfesoterodine produces a dose-dependent inhibition of the intravesical volume-induced urinary bladder contraction measured as the micturition pressure. [3] |
| In vivo | Desfesoterodine is significantly more potent at inhibiting acetylcholine-induced urinary bladder contraction than electrically induced salivation in the anaesthetised cat (ID50 15 and 40 nmol/kg, respectively. Desfesoterodine is three times more potent at the urinary bladder compared to the salivary gland. [1] |
| Synonyms | PNU-200577, 5-hydroxymethyl Tolterodine, 5-HMT, 5-HM, (R)-5-Hydroxymethyl Tolterodine |
| Molecular Weight | 341.49 |
| Formula | C22H31NO2 |
| Cas No. | 207679-81-0 |
| Smiles | CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C |
| Relative Density. | 1.060 g/cm3 (Predicted) |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 63 mg/mL (184.49 mM), Sonication is recommended. DMSO: 65 mg/mL (190.34 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.86 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.